Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial-Reference-Cited by-同舟云学术

Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial

Published:2007-12 Issue:9605 Volume:370 Page:2103-2111
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Escudier Bernard,Pluzanska Anna,Koralewski Piotr,Ravaud Alain,Bracarda Sergio,Szczylik Cezary,Chevreau Christine,Filipek Marek,Melichar Bohuslav,Bajetta Emilio,Gorbunova Vera,Bay Jacques-Olivier,Bodrogi Istvan,Jagiello-Gruszfeld Agnieszka,Moore Nicola

Publisher

Elsevier BV

Subject

General Medicine

Reference43 articles.

1. Estimates of the cancer incidence and mortality in Europe in 2006;Ferlay;Ann Oncol,2007

2. Renal cancer: molecular mechanisms and newer therapeutic options;Karumanchi;Curr Opin Nephrol Hypertens,2002

3. Cancer: principles and practice of oncology;DeVita,2001

4. Renal-cell carcinoma;Motzer;N Engl J Med,1996

5. Nonmetastatic renal cell carcinoma: is it really possible to define rational guidelines for post treatment follow up;Rouviere;Nat Clin Pract Oncol,2006

Cited by 2010 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Surgical metastasectomy for metastatic renal cell carcinoma in the era of targeted and immune therapy: a narrative review;World Journal of Urology;2024-01-20

2. Efficacy of anti‐vascular endothelial growth factor and mitomycin C on wound healing after trabeculectomy in glaucoma patients: A meta‐analysis;International Wound Journal;2023-12-13

3. An Overview of the Use of Anti-Angiogenic Agents in the Treatment of Thymic Epithelial Tumors;International Journal of Molecular Sciences;2023-12-02

4. Schlafen Family Intra-Regulation by IFN-α2 in Triple-Negative Breast Cancer;Cancers;2023-11-30

5. Exploring the role of natural bioactive molecules in genitourinary cancers: how far has research progressed?;Natural Products and Bioprospecting;2023-10-16